Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (CVS). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Wright Reports
|
$495.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
CVS Caremark Corporation Issues Q1, FY 2012 EPS Guidance In Line With Analysts' Estimates
CVS Caremark Corporation announced that for first quarter of 2012, it expects adjusted earnings per share (EPS) in the range of $0.61 to $0.63 and GAAP diluted EPS from continuing operations of $0.55 to $0.57. For fiscal 2012, it expects adjusted EPS of $3.18 to $3.28 and GAAP diluted EPS from continuing operations of $2.96 to 3.06. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $0.61 for first quarter of 2012 and EPS of $3.25 for fiscal 2012.
Latest Developments for CVS Caremark Corp
- Cvs Caremark Corp Raises Low End Of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates; Issues Q2 2013 EPS Guidance In Line With Analysts' Estimates
- Cvs Caremark Corp Buys Drogaria Onofre-Reuters
- Cvs Caremark Corp Raises FY 2013 EPS Guidance
- Cvs Caremark Corp Issues FY 2013 EPS Guidance In Line With Analysts' Estimates-Conference Call
- Share this
- Link this
- Digg this
Follow Reuters